Entrada Therapeutics can plough on with the development of its Duchenne muscular dystrophy (DMD) therapy, ENTR-601-44, now ...

The EMA has granted approval for an additional 2 mL pre-filled pen option for Takeda’s Takhzyro, aimed at treating HAE.

In an anonymous post in the BMJ, the author claims that words relating to DEI could lead to grants being taken away.

Gilead Sciences has announced EMA validation for a parallel accelerated review of lenacapavir’s MAA and EU-M4all applications ...

Sionna Therapeutics recently secured an initial public offering (IPO) of $191m on the Nasdaq stock exchange, signalling ...

The FDA has accepted Bristol Myers Squibb’s (BMS) supplemental biologics licence application (sBLA) for Opdivo and Yervoy ...

SHL Medical’s Elexy is an autoinjection device that combines a pre-filled syringe and cartridge to improve flexibility and efficiency. This video gives an overview of the device’s statistics and ...

Pfizer has signed a deal with Summit Therapeutics to assess the efficacy of Summit’s ivonescimab in combination with several ...

Celltrion has secured marketing authorisation from the EC for Avtozma, a biosimilar to Chugai Pharmaceutical’s RoActemra ...

With Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat versions are no longer allowed – for now.

MeiraGTx’s investigational gene therapy AAV-AIPL1 has improved the sight of 11 children who were born blind. MeiraGTx is ...

Teva Pharmaceuticals and Alvotech have announced the US launch of Selarsdi (ustekinumab-aekn) injection, a biosimilar to ...